スタチン、PCSK9阻害薬、フィブリン酸誘導体などの高脂血症治療薬は、2019年に1,790万人の死因となった心血管疾患(CVD)の主要な危険因子である高コレステロールを管理します。市場を牽引しているのは、CVD罹患率の高さ(世界の成人の33%が高コレステロール)、高齢化(60歳以上の罹患率は40%)、そして肥満などの生活習慣要因(肥満成人は4億2,400万人)です。インクリシランやベンペド酸といった新規治療薬は、服薬遵守が20%向上し、FDA承認の迅速化(市場参入が15%加速)も成長を後押ししています。世界の高脂血症治療薬市場は、2025年には8億〜13億米ドルに達すると推定され、2030年まで年平均成長率(CAGR)は4%〜8%と予測されています。
目次
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Hyperlipidemia Drug Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Hyperlipidemia Drug Market in North America (2020-2030)
8.1 Hyperlipidemia Drug Market Size
8.2 Hyperlipidemia Drug Market by End Use
8.3 Competition by Players/Suppliers
8.4 Hyperlipidemia Drug Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Hyperlipidemia Drug Market in South America (2020-2030)
9.1 Hyperlipidemia Drug Market Size
9.2 Hyperlipidemia Drug Market by End Use
9.3 Competition by Players/Suppliers
9.4 Hyperlipidemia Drug Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Hyperlipidemia Drug Market in Asia & Pacific (2020-2030)
10.1 Hyperlipidemia Drug Market Size
10.2 Hyperlipidemia Drug Market by End Use
10.3 Competition by Players/Suppliers
10.4 Hyperlipidemia Drug Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Hyperlipidemia Drug Market in Europe (2020-2030)
11.1 Hyperlipidemia Drug Market Size
11.2 Hyperlipidemia Drug Market by End Use
11.3 Competition by Players/Suppliers
11.4 Hyperlipidemia Drug Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Hyperlipidemia Drug Market in MEA (2020-2030)
12.1 Hyperlipidemia Drug Market Size
12.2 Hyperlipidemia Drug Market by End Use
12.3 Competition by Players/Suppliers
12.4 Hyperlipidemia Drug Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Hyperlipidemia Drug Market (2020-2025)
13.1 Hyperlipidemia Drug Market Size
13.2 Hyperlipidemia Drug Market by End Use
13.3 Competition by Players/Suppliers
13.4 Hyperlipidemia Drug Market Size by Type
Chapter 14 Global Hyperlipidemia Drug Market Forecast (2025-2030)
14.1 Hyperlipidemia Drug Market Size Forecast
14.2 Hyperlipidemia Drug Application Forecast
14.3 Competition by Players/Suppliers
14.4 Hyperlipidemia Drug Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Pfizer
15.1.1 Company Profile
15.1.2 Main Business and Hyperlipidemia Drug Information
15.1.3 SWOT Analysis of Pfizer
15.1.4 Pfizer Hyperlipidemia Drug Revenue, Gross Margin and Market Share (2020-2025)
15.2 AstraZeneca
15.2.1 Company Profile
15.2.2 Main Business and Hyperlipidemia Drug Information
15.2.3 SWOT Analysis of AstraZeneca
15.2.4 AstraZeneca Hyperlipidemia Drug Revenue, Gross Margin and Market Share (2020-2025)
15.3 Amgen
15.3.1 Company Profile
15.3.2 Main Business and Hyperlipidemia Drug Information
15.3.3 SWOT Analysis of Amgen
15.3.4 Amgen Hyperlipidemia Drug Revenue, Gross Margin and Market Share (2020-2025)
15.4 Sanofi
15.4.1 Company Profile
15.4.2 Main Business and Hyperlipidemia Drug Information
15.4.3 SWOT Analysis of Sanofi
15.4.4 Sanofi Hyperlipidemia Drug Revenue, Gross Margin and Market Share (2020-2025)
15.5 Merck
15.5.1 Company Profile
15.5.2 Main Business and Hyperlipidemia Drug Information
15.5.3 SWOT Analysis of Merck
15.5.4 Merck Hyperlipidemia Drug Revenue, Gross Margin and Market Share (2020-2025)
15.6 Viatris
15.6.1 Company Profile
15.6.2 Main Business and Hyperlipidemia Drug Information
15.6.3 SWOT Analysis of Viatris
15.6.4 Viatris Hyperlipidemia Drug Revenue, Gross Margin and Market Share (2020-2025)
Please ask for sample pages for full companies list
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Hyperlipidemia Drug Report
Table Data Sources of Hyperlipidemia Drug Report
Table Major Assumptions of Hyperlipidemia Drug Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Hyperlipidemia Drug Picture
Table Hyperlipidemia Drug Classification
Table Hyperlipidemia Drug Applications
Table Drivers of Hyperlipidemia Drug Market
Table Restraints of Hyperlipidemia Drug Market
Table Opportunities of Hyperlipidemia Drug Market
Table Threats of Hyperlipidemia Drug Market
Table Covid-19 Impact For Hyperlipidemia Drug Market
Table Raw Materials Suppliers
Table Different Production Methods of Hyperlipidemia Drug
Table Cost Structure Analysis of Hyperlipidemia Drug
Table Key End Users
Table Latest News of Hyperlipidemia Drug Market
Table Merger and Acquisition
Table Planned/Future Project of Hyperlipidemia Drug Market
Table Policy of Hyperlipidemia Drug Market
Table 2020-2030 North America Hyperlipidemia Drug Market Size
Figure 2020-2030 North America Hyperlipidemia Drug Market Size and CAGR
Table 2020-2030 North America Hyperlipidemia Drug Market Size by Application
Table 2020-2025 North America Hyperlipidemia Drug Key Players Revenue
Table 2020-2025 North America Hyperlipidemia Drug Key Players Market Share
Table 2020-2030 North America Hyperlipidemia Drug Market Size by Type
Table 2020-2030 United States Hyperlipidemia Drug Market Size
Table 2020-2030 Canada Hyperlipidemia Drug Market Size
Table 2020-2030 Mexico Hyperlipidemia Drug Market Size
Table 2020-2030 South America Hyperlipidemia Drug Market Size
Figure 2020-2030 South America Hyperlipidemia Drug Market Size and CAGR
Table 2020-2030 South America Hyperlipidemia Drug Market Size by Application
Table 2020-2025 South America Hyperlipidemia Drug Key Players Revenue
Table 2020-2025 South America Hyperlipidemia Drug Key Players Market Share
Table 2020-2030 South America Hyperlipidemia Drug Market Size by Type
Table 2020-2030 Brazil Hyperlipidemia Drug Market Size
Table 2020-2030 Argentina Hyperlipidemia Drug Market Size
Table 2020-2030 Chile Hyperlipidemia Drug Market Size
Table 2020-2030 Peru Hyperlipidemia Drug Market Size
Table 2020-2030 Asia & Pacific Hyperlipidemia Drug Market Size
Figure 2020-2030 Asia & Pacific Hyperlipidemia Drug Market Size and CAGR
Table 2020-2030 Asia & Pacific Hyperlipidemia Drug Market Size by Application
Table 2020-2025 Asia & Pacific Hyperlipidemia Drug Key Players Revenue
Table 2020-2025 Asia & Pacific Hyperlipidemia Drug Key Players Market Share
Table 2020-2030 Asia & Pacific Hyperlipidemia Drug Market Size by Type
Table 2020-2030 China Hyperlipidemia Drug Market Size
Table 2020-2030 India Hyperlipidemia Drug Market Size
Table 2020-2030 Japan Hyperlipidemia Drug Market Size
Table 2020-2030 South Korea Hyperlipidemia Drug Market Size
Table 2020-2030 Southeast Asia Hyperlipidemia Drug Market Size
Table 2020-2030 Australia Hyperlipidemia Drug Market Size
Table 2020-2030 Europe Hyperlipidemia Drug Market Size
Figure 2020-2030 Europe Hyperlipidemia Drug Market Size and CAGR
Table 2020-2030 Europe Hyperlipidemia Drug Market Size by Application
Table 2020-2025 Europe Hyperlipidemia Drug Key Players Revenue
Table 2020-2025 Europe Hyperlipidemia Drug Key Players Market Share
Table 2020-2030 Europe Hyperlipidemia Drug Market Size by Type
Table 2020-2030 Germany Hyperlipidemia Drug Market Size
Table 2020-2030 France Hyperlipidemia Drug Market Size
Table 2020-2030 United Kingdom Hyperlipidemia Drug Market Size
Table 2020-2030 Italy Hyperlipidemia Drug Market Size
Table 2020-2030 Spain Hyperlipidemia Drug Market Size
Table 2020-2030 Belgium Hyperlipidemia Drug Market Size
Table 2020-2030 Netherlands Hyperlipidemia Drug Market Size
Table 2020-2030 Austria Hyperlipidemia Drug Market Size
Table 2020-2030 Poland Hyperlipidemia Drug Market Size
Table 2020-2030 Russia Hyperlipidemia Drug Market Size
Table 2020-2030 MEA Hyperlipidemia Drug Market Size
Figure 2020-2030 MEA Hyperlipidemia Drug Market Size and CAGR
Table 2020-2030 MEA Hyperlipidemia Drug Market Size by Application
Table 2020-2025 MEA Hyperlipidemia Drug Key Players Revenue
Table 2020-2025 MEA Hyperlipidemia Drug Key Players Market Share
Table 2020-2030 MEA Hyperlipidemia Drug Market Size by Type
Table 2020-2030 Egypt Hyperlipidemia Drug Market Size
Table 2020-2030 Israel Hyperlipidemia Drug Market Size
Table 2020-2030 South Africa Hyperlipidemia Drug Market Size
Table 2020-2030 Gulf Cooperation Council Countries Hyperlipidemia Drug Market Size
Table 2020-2030 Turkey Hyperlipidemia Drug Market Size
Table 2020-2025 Global Hyperlipidemia Drug Market Size by Region
Table 2020-2025 Global Hyperlipidemia Drug Market Size Share by Region
Table 2020-2025 Global Hyperlipidemia Drug Market Size by Application
Table 2020-2025 Global Hyperlipidemia Drug Market Share by Application
Table 2020-2025 Global Hyperlipidemia Drug Key Vendors Revenue
Figure 2020-2025 Global Hyperlipidemia Drug Market Size and Growth Rate
Table 2020-2025 Global Hyperlipidemia Drug Key Vendors Market Share
Table 2020-2025 Global Hyperlipidemia Drug Market Size by Type
Table 2020-2025 Global Hyperlipidemia Drug Market Share by Type
Table 2025-2030 Global Hyperlipidemia Drug Market Size by Region
Table 2025-2030 Global Hyperlipidemia Drug Market Size Share by Region
Table 2025-2030 Global Hyperlipidemia Drug Market Size by Application
Table 2025-2030 Global Hyperlipidemia Drug Market Share by Application
Table 2025-2030 Global Hyperlipidemia Drug Key Vendors Revenue
Figure 2025-2030 Global Hyperlipidemia Drug Market Size and Growth Rate
Table 2025-2030 Global Hyperlipidemia Drug Key Vendors Market Share
Table 2025-2030 Global Hyperlipidemia Drug Market Size by Type
Table 2025-2030 Hyperlipidemia Drug Global Market Share by Type